Synthesis of benzylidene-indandione derivatives as quantification of amyloid fibrils.

Seyyed Abolghasem Ghadami, Kimia Ahadi-Amandi, Reza Khodarahmi, Saba Ghanbari, Hadi Adibi

Biophysical chemistry 2023 May

filter terms:

The formation of amyloid fibrils due to its association with fatal diseases, including Alzheimer's, has been investigated by many researchers. These common diseases, mostly become verified when it is too late to be treated. Currently, no cure is available for neurodegenerative diseases, and the process of diagnosing amyloid fibrils in the early stages, while there are fewer amyloid fibrils, has become an issue of interest. To do so, determining new probes with the highest binding affinity to the lowest number of amyloid fibrils is necessary. In this study, we proposed to employ new synthesized benzylidene-indandione derivatives as amyloid fibrils fluorescent detection probes. Native soluble proteins of insulin, bovine serum albumin (BSA), BSA amorphous aggregation, and insulin amyloid fibrils were used to evaluate our compounds' specificity to the amyloid structure. While ten synthesized compounds were examined individually, four of them including 3d, 3g, 3i, and 3j showed a high binding affinity with selectivity and specificity to amyloid fibrils, and their binding properties were also confirmed with in silico analysis. The drug-likeness prediction results for selected compounds by Swiss ADME server shows a satisfactory percentage of blood-brain barrier (BBB) permeability and gastrointestinal (GI) absorption for the compounds 3g, 3i, and 3j. More evaluation is needed to determine all properties of compounds in vitro and in vivo. Copyright © 2023 Elsevier B.V. All rights reserved.

Citation

Seyyed Abolghasem Ghadami, Kimia Ahadi-Amandi, Reza Khodarahmi, Saba Ghanbari, Hadi Adibi. Synthesis of benzylidene-indandione derivatives as quantification of amyloid fibrils. Biophysical chemistry. 2023 May;296:106982